Zweig-DiMenna Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-160,198	Closed	-$13.2M	–	153
2016 Q1	$13.2M	Buy	160,198 +70,198	+78%	+$5.71M	1.17%	30
2015 Q4	$9.43M	Sell	90,000 -206,065	-70%	-$21.5M	0.48%	74
2015 Q3	$31.2M	Buy	296,065 +243,565	+464%	+$32.5M	1.49%	17
2015 Q2	$7.18M	Sell	52,500 -67,000	-56%	-$8.3M	0.41%	71
2015 Q1	$14.9M	Sell	119,500 -115,587	-49%	-$12.2M	0.65%	65
2014 Q4	$21.3M	Buy	235,087 +178,349	+314%	+$14.8M	0.97%	37
2014 Q3	$4.09M	Sell	56,738 -87,937	-61%	-$5.78M	0.21%	118
2014 Q2	$9M	Buy	144,675 +15,000	+12%	+$906K	0.45%	77
2014 Q1	$8.85M	Sell	129,675 -476,174	-79%	-$35.1M	0.53%	67
2013 Q4	$42.6M	Buy	605,849 +36,245	+6%	+$2.46M	1.61%	12
2013 Q3	$41.1M	Buy	569,604 +113,912	+25%	+$7.57M	1.68%	7
2013 Q2	$25.4M	Buy	+455,692	New	+$28.4M	1.16%	21